0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.24%
Positive revenue growth while 0335.HK is negative. John Neff might see a notable competitive edge here.
9.27%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
-4.45%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.45%
Negative operating income growth while 0335.HK is at 28.58%. Joel Greenblatt would press for urgent turnaround measures.
23.51%
Net income growth under 50% of 0335.HK's 47.98%. Michael Burry would suspect the firm is falling well behind a key competitor.
21.43%
EPS growth under 50% of 0335.HK's 48.28%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
21.43%
Diluted EPS growth under 50% of 0335.HK's 48.28%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.69%
Slight or no buybacks while 0335.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.59%
Diluted share change of 1.59% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
19.78%
OCF growth under 50% of 0335.HK's 207.49%. Michael Burry might suspect questionable revenue recognition or rising costs.
25.16%
FCF growth under 50% of 0335.HK's 207.20%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
21014.84%
10Y revenue/share CAGR above 1.5x 0335.HK's 381.95%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
24.65%
5Y revenue/share CAGR at 50-75% of 0335.HK's 35.46%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-3.39%
Negative 3Y CAGR while 0335.HK stands at 534.72%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-9466.85%
Negative 10Y OCF/share CAGR while 0335.HK stands at 458.74%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-5313.50%
Negative 5Y OCF/share CAGR while 0335.HK is at 447.83%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1349.92%
Negative 3Y OCF/share CAGR while 0335.HK stands at 549.55%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
23.83%
Positive 10Y CAGR while 0335.HK is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-22.39%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
13.82%
Below 50% of 0335.HK's 109.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
95.36%
5Y equity/share CAGR 1.25-1.5x 0335.HK's 82.62%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
40.98%
3Y equity/share CAGR at 50-75% of 0335.HK's 66.45%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
93.73%
Below 50% of 0335.HK's 200.05%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
84.64%
3Y dividend/share CAGR similar to 0335.HK's 87.49%. Walter Schloss finds parallel short-term dividend strategies for both companies.
47.11%
AR growth of 47.11% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-21.61%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
22.34%
Asset growth above 1.5x 0335.HK's 2.64%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.73%
BV/share growth above 1.5x 0335.HK's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1816.96%
Debt growth far above 0335.HK's 25.96%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
80.16%
R&D growth of 80.16% while 0335.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
47.97%
SG&A growth well above 0335.HK's 7.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.